Related Experiment Video
Updated: May 24, 2026
Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages
Published on: March 24, 2023
Assessment of cochlear implant candidacy in patients with cochlear nerve deficiency using the P1 CAEP biomarker
Peter Roland1, Kathryn Henion, Timothy Booth
1Department of Otolaryngology Head and Neck Surgery, University of Texas Southwestern Medical Center at Dallas, TX, USA.
Insights
The P1 cortical auditory evoked potential (CAEP) biomarker shows promise as an objective tool for evaluating cochlear implant (CI) candidacy in children with cochlear nerve deficiency (CND). This biomarker can help identify suitable candidates when other tests are inconclusive.
Area of Science:
- Audiology
- Neuroscience
- Pediatrics
Background:
- Cochlear implantation is a common procedure for severe hearing loss.
- Cochlear nerve deficiency (CND) presents challenges in determining cochlear implant (CI) candidacy.
- Magnetic Resonance Imaging (MRI) is the gold standard for CND diagnosis but may not fully clarify candidacy.
Purpose of the Study:
- To evaluate the P1 cortical auditory evoked potential (CAEP) as an objective biomarker for CI candidacy in children with CND.
- To determine if P1 CAEPs can aid in audiological and radiological assessments for CI in this population.
Main Methods:
- A retrospective case study of four pediatric patients with CND and severe-to-profound sensorineural hearing loss.
- Analysis of audiological, radiological, and P1 CAEP findings, focusing on response presence and latency.
Main Results:
- Three of the four children exhibited robust P1 CAEP responses, indicating central auditory pathway activation.
- These positive responses suggested suitability for cochlear implantation despite the CND diagnosis.
Conclusions:
- P1 CAEPs may serve as a valuable objective tool to supplement existing diagnostic methods for CI candidacy in children with CND.
- Integrating P1 CAEPs into the test battery could improve decision-making for cochlear implantation in complex cases of CND.
Objective:
The goal of this report was to ascertain the efficacy of the P1 cortical auditory evoked potential (CAEP) biomarker as an objective tool to assist in the evaluation of cochlear implant (CI) candidacy in children with a radiological diagnosis of cochlear nerve deficiency (CND).
Methods:
Retrospective case study review of audiological and radiological findings was performed in four pediatric patients identified with CND and severe-to-profound sensorineural hearing loss. Cortical auditory evoked potential testing was conducted, and the presence and latency of the P1 component were analyzed.
Results:
Three out of four children demonstrated robust P1 CAEP responses, indicating activation of the central auditory pathways by auditory stimulation, despite the diagnosis of CND. These children were considered good candidates for cochlear implantation.
Discussion:
Although cochlear implantation in children is a fairly routine procedure, cases exist for which implant candidacy is questionable. Among these cases are children with CND. In these children, cochlear implantation may be contraindicated due to the likelihood that the implant electrodes may not stimulate the VIII nerve adequately. Magnetic resonance imaging (MRI) is considered the gold standard in the assessment of CND, but this measure is not always sufficient to determine CI candidacy in cases of CND. The addition of the P1 CAEP measurement to the usual electrophysiological, audiometric, and radiological test battery may prove to be useful in determining CI options for children with CND.